跳至主要内容
临床试验/NCT06324825
NCT06324825招募中不适用

Fuzhegn Nizeng Formula for Chronic Atrophic Gastritis With Low-grade Intraepithelial Neoplasia, a Multicenter Randomized Controlled Trial

Peking University First Hospital1 个研究点 分布在 1 个国家目标入组 144 人开始时间: 2022年10月24日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
招募中
入组人数
144
试验地点
1
主要终点
Recovery rate of Low-grade Intraepithelial Neoplasia

研究概览

简要总结

Fuzheng Nizeng Formula (FZNZ) is derived from the classic formula Liujunzi Decoction. Former pilot study found that FZNZ promoted the recovery of gastric atrophy and relieve the relative symptoms. This study is to evaluate its efficacy for chronic atrophic gastritis with low-grade intraepithelial neoplasia, compared with positive control Molduodan granule.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Chronic Atrophic Gastritis With Low-grade Intraepithelial Neoplasia diagnosed by endoscopy and stomach biopsy.
  • Helicobacter pylori negative.
  • TCM syndrome is spleen-stomach deficiency with blood stasis and phelgm.

排除标准

  • History of gastric surgery.
  • Combined with malignant tumor.
  • History of mental illness.
  • Allergy to any components of the drug use in the study.
  • Planning to pregnancy, or pregnant woman and lactating woman.

研究组 & 干预措施

Fuzhegn Nizeng Formula

Experimental

干预措施: Fuzhegn Nizeng Decoction (Drug)

Moluodan patient medicine

Active Comparator

干预措施: Moluodan granules (Drug)

结局指标

主要结局

Recovery rate of Low-grade Intraepithelial Neoplasia

时间窗: The 180 days after drug administration.

Stomach biopsy will be taken after drug administration completion.

次要结局

  • Adverse event rate(The 6 months during the drug administration)
  • 7-point Global Overall Symptom Scale(1st, 2nd, 3rd, 4th, 5th, 6th month)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Fuzheng Nizeng Formula for Chronic Atrophic... | 临床试验